Improved Immune-suppression Techniques for the Exongrafting of Human Tumours
Overview
Authors
Affiliations
The transplantability of a xenografted human adenocarcinoma has been examined in mice that had been immune-suppressed by thymectomy and whole-body irradiation and the results have been compared with transplantation into athymic (nude) mice. Two alternative techniques were used to prevent marrow failure following whole-body irradiation: reconstituting the animals with a marrow graft, or protecting them by an injection of cytosine arabinoside (Ara-C) 2 days before the irradiation. The results show that the Ara-C-prepared mice were more receptive to transplantation than marrow-grafted or nude mice, and they were the only animals that developed regional metastases from implanted xenografts. Some recovery of immunity occurred in both types of immune-suppressed mice, which was evident more than 5 weeks after immune-suppression and which was more marked in females than in males. It was concluded that the immune-suppressed mice were superior to nude mice for short-term experiments but they may be less satisfactory for long-term experiments.
How can grafted breast cancer models be optimized?.
Mollard S, Mousseau Y, Baaj Y, Richard L, Cook-Moreau J, Monteil J Cancer Biol Ther. 2011; 12(10):855-64.
PMID: 22057217 PMC: 3280900. DOI: 10.4161/cbt.12.10.18139.
Vincze B, PALYI I, Daubner D, Kalnay A, Mezo G, Hudecz F J Cancer Res Clin Oncol. 1994; 120(10):578-84.
PMID: 7929528 DOI: 10.1007/BF01212811.
Clonogenic cell survival in cryopreserved human tumour cells.
Selby P, STEEL G Br J Cancer. 1981; 43(2):143-8.
PMID: 7470378 PMC: 2010530. DOI: 10.1038/bjc.1981.22.
Comparative functional histopathology of human breast carcinoma xenografts.
Bailey M, Ormerod M, Imrie S, Humphreys J, Roberts J, Gazet J Br J Cancer. 1981; 43(2):125-34.
PMID: 7470377 PMC: 2010529. DOI: 10.1038/bjc.1981.20.
Colony growth and clonogenic cell survival in human melanoma xenografts treated with chemotherapy.
Selby P, COURTENAY V, McElwain T, Peckham M, STEEL G Br J Cancer. 1980; 42(3):438-47.
PMID: 7426346 PMC: 2010421. DOI: 10.1038/bjc.1980.256.